SCHEMBL29978502

SCHEMBL29978502

NCC1COc2ccc(NC(=O)Nc3ccc4cc[nH]c4c3)cc2N1Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CCR3 P51677 2/20 0.38
▸ FAAH O00519 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ PYGL P06737 1/20 0.38
▸ CFTR P13569 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ GABRA4 P48169 1/20 0.38
▸ GABRA6 Q16445 1/20 0.38
▸ MAOA P21397 1/20 0.37
▸ NOTUM Q6P988 1/20 0.37
▸ NPY1R P25929 2/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ NR3C2 P08235 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25138429 1.00 HTT (0.39) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL23769526 0.93 NR3C1 (0.40) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL29979331 0.93 NR3C1 (0.40) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL29978800 0.90 SMN1; SMN2 (0.38) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL23769122 0.90 SMN1; SMN2 (0.38) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL23769118 0.89 SMN1; SMN2 (0.37) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL29978520 0.89 SMN1; SMN2 (0.37) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL23769008 0.88 HTT (0.39) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL29979018 0.88 HTT (0.39) HTTSMN1; SMN2CCR3FAAHMAPK14
SCHEMBL23769066 0.88 CCR3 (0.36) HTTSMN1; SMN2CCR3FAAHMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 — — CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 — — CN claimed
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 — — CN disclosed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS HTT 4681/4885SMN1; SMN2 1579/4885CCR3 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback